Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements
Lifecore receives amendment and waiver for its term debt facility with Alcon and BMO
Related news for (LFCR)
- Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
- Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
- Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
- Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
- Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome